Australia

CSL Seqirus CSL plant Melbourne Australia CSL Seqiris plant flu shot plant influenza
Manufacturing

Its future murky, CSL Seqirus opens $1B vax plant in Australia

CSL Seqirus has opened the doors to a new $1 billion cell-based influenza vaccine and antivenom facility in Melbourne.
Joseph Keenan Dec 9, 2025 9:08am
Withdraw cancel rip up application

Australian government blocks Cosette's Mayne Pharma buy

Nov 21, 2025 11:36am
pill bacteria antimicrobial resistance

Pfizer beefs up its antimicrobial manufacturing in Australia

Aug 6, 2024 2:16pm
radiopharmaceuticals

Telix takes on isotope manufacturer ARTMS for up to $82M

Mar 5, 2024 1:29pm
blueprint construction hard hat hammer build

Noumed Pharma breaks ground on $65M manufacturing plant

Feb 27, 2024 8:10am
University of Queensland COVID-19 vaccine patch

Needle-free vaccine maker Vaxxas opens new Australian facility

Jun 21, 2023 1:14pm